🇺🇸 FDA
Patent

US 12297259

Aspergillus antigen chimeric receptors and use thereof

granted A61KA61K2239/13A61K39/0002

Quick answer

US patent 12297259 (Aspergillus antigen chimeric receptors and use thereof) held by The Board of Regents of the University of Texas System expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2239/13, A61K39/0002, A61K40/10, A61K40/31